These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28943551)

  • 1. Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report.
    Oka H; Kamimura T; Hiramatsu Y; Fukumitsu K; Iwata R; Kondo M; Hirashima Y; Aihara S; Harada A; Tsuruya K
    Intern Med; 2018 Jan; 57(1):71-74. PubMed ID: 28943551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism.
    Shirley M; Dhillon S
    Drugs; 2015 Nov; 75(17):2025-34. PubMed ID: 26546477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
    Bohula EA; Giugliano RP; Ruff CT; Kuder JF; Murphy SA; Antman EM; Braunwald E
    Circulation; 2016 Jul; 134(1):24-36. PubMed ID: 27358434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
    van Es N; Di Nisio M; Bleker SM; Segers A; Mercuri MF; Schwocho L; Kakkar A; Weitz JI; Beyer-Westendorf J; Boda Z; Carrier M; Chlumsky J; Décousus H; Garcia D; Gibbs H; Kamphuisen PW; Monreal M; Ockelford P; Pabinger I; Verhamme P; Grosso MA; Büller HR; Raskob GE
    Thromb Haemost; 2015 Nov; 114(6):1268-76. PubMed ID: 26271200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset of cholesterol crystal embolism after thrombolysis for cerebral infarction.
    Oe K; Araki T; Nakashima A; Sato K; Konno T; Yamagishi M
    Intern Med; 2010; 49(9):833-6. PubMed ID: 20453403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.
    Ohmori H; Nakamura M; Kada A; Saito AM; Sanayama Y; Shinagawa T; Fujita H; Wakisaka A; Maruhashi K; Okumura A; Takizawa N; Murata H; Inoue M; Kaneko H; Taniguchi H; Kawasaki M; Sano N; Akaboshi S; Tanuma N; Sone S; Kumode M; Takechi T; Koretsune Y; Sumimoto R; Miyanomae T
    Kurume Med J; 2018 Dec; 65(1):11-16. PubMed ID: 30158356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edoxaban (Lixiana°).
    Prescrire Int; 2017 Jan; 26(178):13-14. PubMed ID: 30730636
    [No Abstract]   [Full Text] [Related]  

  • 8. Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome.
    Shimada Y; Nagaba Y; Nagaba H; Kamata M; Murano J; Kamata F; Okina C; Nonoguchi H; Shimada H; Takeuchi Y
    Intern Med; 2017 Sep; 56(17):2307-2310. PubMed ID: 28794382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].
    Meddahi S; Samama MM
    J Mal Vasc; 2014 May; 39(3):183-94. PubMed ID: 24650612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
    Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
    Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2018 Jul; 46(1):95-101. PubMed ID: 29704172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
    Fuji T; Wang CJ; Fujita S; Kawai Y; Nakamura M; Kimura T; Ibusuki K; Ushida H; Abe K; Tachibana S
    Thromb Res; 2014 Dec; 134(6):1198-204. PubMed ID: 25294589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edoxaban: Efficacy, Laboratory Monitoring, and Approach to Reversal.
    Gehrie EA; Tormey CA
    Arch Pathol Lab Med; 2015 Dec; 139(12):1479. PubMed ID: 26619017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stroke prevention in the elderly: effectiveness and safety of edoxaban in elderly patients according to the results of the ENGAGE AF study].
    Márk L
    Orv Hetil; 2018 May; 159(20):798-802. PubMed ID: 29754512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The ENGAGE AF-TIMI 48 study].
    Rubboli A; Colonna P
    G Ital Cardiol (Rome); 2015 Sep; 16(9):457-61. PubMed ID: 26418383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hokusai-VTE: edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism].
    Sprynger M
    Rev Med Liege; 2013 Oct; 68(10):548-51. PubMed ID: 24298731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis of Large Aneurysm Induced by Flow-Diverter Stent and Dissolved by Direct Factor Xa Inhibitor.
    Higashi E; Hatano T; Ando M; Chihara H; Ogura T; Suzuki K; Yamagami K; Kondo D; Kamata T; Sakai S; Sakamoto H; Nagata I
    World Neurosurg; 2019 Nov; 131():209-212. PubMed ID: 31442658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
    Goette A; Merino JL; Ezekowitz MD; Zamoryakhin D; Melino M; Jin J; Mercuri MF; Grosso MA; Fernandez V; Al-Saady N; Pelekh N; Merkely B; Zenin S; Kushnir M; Spinar J; Batushkin V; de Groot JR; Lip GY;
    Lancet; 2016 Oct; 388(10055):1995-2003. PubMed ID: 27590218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edoxaban Was Effective for the Treatment of Deep Vein Thrombosis and Pulmonary Thromboembolism in a Cancer Patient with Antithrombin III Deficiency.
    Kawano H; Maemura K
    Intern Med; 2016; 55(22):3285-3289. PubMed ID: 27853070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Edoxaban is safer than vitamin K antagonists].
    Einecke D
    MMW Fortschr Med; 2013 Sep; 155(16):20. PubMed ID: 24279137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.